TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - SMT; Philips; Novartis; Merillife
• Consultant Fee/Honoraria/Speaker's Bureau (Institutional) - Xeltis